What is it about?
In bipolar disorder (BD), adjunctive therapies are those are used in combination with primary treatments for the condition. This paper reports adjunctive treatment options are increasing for BD. There are benefits with current pharmacological and psychological treatments, however there is still a large gap between improvement in symptoms and full functional recovery for patients, thus further research is needed.
Featured Image
Why is it important?
Non-pharmacological low-risk adjunctive treatments for BD are reviewed, including nutraceuticals, hormone therapy, psychoeducation and other psychological approaches, brain stimulation methods (TMS), and telehealth/m-health techniques. This paper provides an up-to-date summary and resource for clinicians in the field, which can be used to inform patients of new BD treatments under investigation.
Perspectives
Other translational research programs in biological psychiatry such as #PrecisionSwitchMedicine also aim to provide novel diagnostic, genetic and therapeutic brain stimulation options for BD and related disorders (e.g., depression, schizophrenia).
Dr Trung Thành Ngô
RECOVER Injury Research Centre — University of Queensland and Surgical, Treatment & Rehabilitation Service (STARS)
Read the Original
This page is a summary of: An update on adjunctive treatment options for bipolar disorder, Bipolar Disorders, January 2018, Wiley,
DOI: 10.1111/bdi.12601.
You can read the full text:
Contributors
The following have contributed to this page
